Aadi Bioscience (AADI) Competitors $2.13 -0.09 (-4.05%) As of 10/8/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock AADI vs. SXTC, CLLS, FTLF, DERM, BHST, APLT, GNFT, CHRS, PLX, and FBRXShould you be buying Aadi Bioscience stock or one of its competitors? The main competitors of Aadi Bioscience include China SXT Pharmaceuticals (SXTC), Cellectis (CLLS), FitLife Brands (FTLF), Journey Medical (DERM), BioHarvest Sciences (BHST), Applied Therapeutics (APLT), GENFIT (GNFT), Coherus Oncology (CHRS), Protalix BioTherapeutics (PLX), and Forte Biosciences (FBRX). These companies are all part of the "pharmaceutical products" industry. Aadi Bioscience vs. Its Competitors China SXT Pharmaceuticals Cellectis FitLife Brands Journey Medical BioHarvest Sciences Applied Therapeutics GENFIT Coherus Oncology Protalix BioTherapeutics Forte Biosciences China SXT Pharmaceuticals (NASDAQ:SXTC) and Aadi Bioscience (NASDAQ:AADI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, profitability, valuation, risk and institutional ownership. Does the media prefer SXTC or AADI? In the previous week, China SXT Pharmaceuticals had 3 more articles in the media than Aadi Bioscience. MarketBeat recorded 3 mentions for China SXT Pharmaceuticals and 0 mentions for Aadi Bioscience. China SXT Pharmaceuticals' average media sentiment score of 0.83 beat Aadi Bioscience's score of 0.00 indicating that China SXT Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment China SXT Pharmaceuticals Positive Aadi Bioscience Neutral Do insiders and institutionals have more ownership in SXTC or AADI? 5.0% of China SXT Pharmaceuticals shares are owned by institutional investors. Comparatively, 52.1% of Aadi Bioscience shares are owned by institutional investors. 4.0% of China SXT Pharmaceuticals shares are owned by company insiders. Comparatively, 37.3% of Aadi Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has better valuation and earnings, SXTC or AADI? China SXT Pharmaceuticals has higher earnings, but lower revenue than Aadi Bioscience. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChina SXT Pharmaceuticals$1.74M103.30-$3.30MN/AN/AAadi Bioscience$25.07M2.10-$65.76M-$2.35-0.91 Do analysts prefer SXTC or AADI? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score China SXT Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Aadi Bioscience 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk and volatility, SXTC or AADI? China SXT Pharmaceuticals has a beta of 1.36, meaning that its stock price is 36% more volatile than the S&P 500. Comparatively, Aadi Bioscience has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500. Is SXTC or AADI more profitable? China SXT Pharmaceuticals has a net margin of 0.00% compared to Aadi Bioscience's net margin of -246.06%. China SXT Pharmaceuticals' return on equity of 0.00% beat Aadi Bioscience's return on equity.Company Net Margins Return on Equity Return on Assets China SXT PharmaceuticalsN/A N/A N/A Aadi Bioscience -246.06%-71.87%-57.28% SummaryChina SXT Pharmaceuticals beats Aadi Bioscience on 9 of the 12 factors compared between the two stocks. Get Aadi Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for AADI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AADI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AADI vs. The Competition Export to ExcelMetricAadi BiosciencePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$52.61M$1.03B$6.14B$10.64BDividend YieldN/A4.84%5.66%4.69%P/E Ratio-0.931.2585.7227.64Price / Sales2.1030.85631.45142.60Price / CashN/A17.6438.3262.20Price / Book0.507.3613.096.79Net Income-$65.76M-$7.96M$3.30B$275.88M7 Day Performance9.79%30.95%3.75%1.84%1 Month Performance18.33%28.00%10.73%8.84%1 Year Performance7.04%-6.57%85.28%36.10% Aadi Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AADIAadi BioscienceN/A$2.13-4.1%N/A+7.0%$52.61M$25.07M-0.9340SXTCChina SXT Pharmaceuticals0.4745 of 5 stars$1.62-0.6%N/A-65.4%$189.12M$1.74M0.0090News CoverageAnalyst ForecastGap UpCLLSCellectis0.7688 of 5 stars$2.84-15.5%$4.00+40.8%+108.5%$186.76M$49.22M-3.46290News CoveragePositive NewsAnalyst ForecastGap DownHigh Trading VolumeFTLFFitLife Brands3.868 of 5 stars$19.91+0.2%$23.00+15.5%+25.7%$186.70M$64.47M23.7020News CoverageAnalyst ForecastDERMJourney Medical1.9029 of 5 stars$7.10+0.6%$12.17+71.4%+26.9%$185.75M$56.13M-18.6890News CoveragePositive NewsAnalyst ForecastBHSTBioHarvest Sciences2.0278 of 5 stars$9.96-8.5%$13.67+37.2%N/A$178.87M$30.19M-14.23N/AAnalyst ForecastAPLTApplied Therapeutics3.6286 of 5 stars$0.61-50.7%$4.13+574.1%-87.2%$178.57M$460K-1.3630Gap DownHigh Trading VolumeGNFTGENFIT1.6691 of 5 stars$3.65+2.8%$7.00+91.8%-22.9%$177.51M$76.77M0.00120Positive NewsGap UpCHRSCoherus Oncology4.2522 of 5 stars$1.70+13.3%$4.51+165.4%+82.0%$174.34M$272.21M1.10330Analyst ForecastPLXProtalix BioTherapeutics1.8965 of 5 stars$2.16+4.9%$15.00+594.4%+153.5%$172.22M$61.95M-16.62200FBRXForte Biosciences2.8576 of 5 stars$14.48+4.6%$68.00+369.6%+202.8%$172.07MN/A-0.895Positive NewsAnalyst Forecast Related Companies and Tools Related Companies SXTC Competitors CLLS Competitors FTLF Competitors DERM Competitors BHST Competitors APLT Competitors GNFT Competitors CHRS Competitors PLX Competitors FBRX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AADI) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredToo busy for AI trading?Last week, Nvidia and AMD stock soared as export restrictions eased. Nvidia alone gained nearly 5% in a sin...Timothy Sykes | SponsoredHow to Cash In on Trump’s Digital Current - Move By This ThursdayBitcoin Breakout: What Most Investors Are Missing Washington just approved more crypto legislation in 90 da...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aadi Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aadi Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
